Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Will Plummet On New Quigley Lawsuit Developments
Seeking Alpha
Sunday, April 15, 2012 - 12:30pm
tags:
Pfizer, lawsuits
Pfizer: Quality Dividend Stock At A Bargain Price
Seeking Alpha
Sunday, April 15, 2012 - 12:29pm
tags:
Pfizer
Samsung eyes generic biological medicines
Financial Times, UK
Sunday, April 15, 2012 - 12:27pm
tags:
Samsung, generics, biogenerics
Spectrum Will Surge Higher On FOTOLYN Approval
Seeking Alpha
Sunday, April 15, 2012 - 12:25pm
tags:
Spectrum Pharmaceuticals, Fotolyn, lymphoma, T-cell lymphoma
Curis Operable BCC Human Data: Early Results And Further Commentary
Seeking Alpha
Sunday, April 15, 2012 - 12:23pm
tags:
Erivedge, Curis, Roche, basal cell carcinoma
Actos Lawsuits Gaining Momentum In Illinois State Court
DrugWatch
Saturday, April 14, 2012 - 1:41pm
tags:
Actos, diabetes, lawsuits
3 Outperforming Small Caps Bought Up By Insiders And Hedge Funds
Seeking Alpha
Saturday, April 14, 2012 - 1:38pm
tags:
Furiex Pharmaceuticals, Pacira
Valeant in Expansion Mode - Analyst Blog
Nasdaq
Saturday, April 14, 2012 - 1:36pm
tags:
Valeant Pharmaceuticals, Pedinol Pharmacal, M&A
AstraZeneca CEO faces familiar question on how to grow
MedCity News
Saturday, April 14, 2012 - 1:19pm
tags:
AstraZeneca, David Brennan
Amgen to Acquire Privately Held KAI Pharmaceuticals
Pharmalive
Saturday, April 14, 2012 - 1:17pm
tags:
Amgen, KAI Pharmaceuticals
Is Teva About to Tear Itself Apart?
Motley Fool
Saturday, April 14, 2012 - 1:16pm
tags:
Teva Pharmaceuticals
Intellipharmaceutics Announces First Quarter 2012 Results
4-Traders
Saturday, April 14, 2012 - 1:05pm
tags:
Intellipharmaceutics
Gilead Sciences: Highest Returning Protected Covered Call
Seeking Alpha
Saturday, April 14, 2012 - 1:04pm
tags:
Gilead Sciences
Deals Of The Week: Will Lightning Strike Twice At Shire
In Vivo Blog
Saturday, April 14, 2012 - 1:03pm
tags:
Shire, Pervasis Therapeutics, regenerative medicine
AstraZeneca works toward tropical disease cures
Delaware Online, DE
Saturday, April 14, 2012 - 1:01pm
tags:
AstraZeneca, Chagas disease, leishmaniasis
Catalent pairs with BASF on biovailability challenges
NJ Biz, NJ
Saturday, April 14, 2012 - 12:58pm
tags:
Catalent, BASF
Pharma companies cozy up to VC firms
Mass HiTech
Saturday, April 14, 2012 - 12:56pm
tags:
Mylan Launches First Generic Version of Lescol® Capsules
Health Care Global
Saturday, April 14, 2012 - 12:46pm
tags:
Mylan, Lescol, Novartis, generics
More Hair, Less Reason for It
Motley Fool
Saturday, April 14, 2012 - 12:42pm
tags:
Merck, Propecia, sexual dysfunction
Biogen's Fampyra Launched in Canada
Yahoo/Zacks
Saturday, April 14, 2012 - 12:39pm
tags:
Biogen Idec, Fampyra, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.